Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901
Carleen Cullinane, Kelly L Waldeck, David Binns, Ekaterina Bogatyreva, Daniel P Bradley, Ron de Jong, Grant A McArthur, Rodney J Hicks
Nuclear Medicine and Biology | ELSEVIER SCIENCE INC | Published : 2014
This work was supported by a grant received by Grant McArthur and Rodney Hicks from Millennium Pharmaceuticals. Grant McArthur is an uncompensated consultant for Millennium Pharmaceuticals. Daniel Bradley and Ron de Jong are employees of Millennium: The Takeda Oncology Company. The remaining authors have no competing interests.